Cancer care (or any care for that matter) shouldn’t be a postcode lottery. It shouldn’t matter what country in the UK you live in…or, for that matter, what town…
But sadly this is not the case.
In ovarian cancer Avastin (bevacizumab) is an amazing drug that works by preventing ovarian cancer from developing new blood vessels and ‘recovering’ from the damage chemo is doing to our tumours.
Ovarian cancer is renowned for becoming resistant to chemotherapy. Avastin helps postpone this.
It is given to woman with stage 3 and stage 4 ovarian cancer.
At this stage our cancer is incurable.
Avastin gives us time.
Time with family. Time with loved ones. Time when our cancer isn’t spreading.
But it isn’t given to all of us.
Whilst I am lucky enough to receive treatment from an NHS trust that administers Avastin, neither the National Institute for Health and Clinical Excellence (NICE) in England, nor the Scottish Medicines Consortium (SMC) in Scotland have recommended its use. It is also not administered in Northern Irland or Wales.
Whilst some people are given it as part of a clinical trial, or if their NHS board has specialist funding, everyone else has to make a choice to move house or to go without.
To go without that extra time…
But…you can help ensure every woman with ovarian cancer is given Avastin.
You can help ensure grandmothers, mothers, daughters, sisters, aunts and friends have more time…
The Westminster Government is currently reforming the Cancer Drugs Fund (CDF).
You can write to your MP asking them to raise this with the Secretary of State for Health.
It will take you less than 2 minutes.
It could give thousands of woman another 9 months.
2 minutes of your time for 9 months of theirs.
Think about it..but not for too long…
Do the right thing.
Thank you on behalf of every woman still to be diagnosed* with late stage ovarian cancer.
Love and light, Fi xx
*whilst under the proposed reforms there is a risk that Avastin (bevacizumab) might not be available to women diagnosed with ovarian cancer in the future it will continue to be available to women receiving it now.